Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026
      Bank of England

      Prudential Regulation Authority Publishes New Funded Reinsurance Regulations

      April 29, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      CHIP Mortgage Trust Issues C$200m of Medium-Term Notes

      April 29, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Using Electronic Health Records in Life Settlement Underwriting

    Secondary Life Markets August 15, 2024By Roger Tafoya
    Share
    Twitter LinkedIn Email

    The underwriting process in life settlements is crucial as it helps determine the fair market value of the policy by assessing a key pricing variable, the life expectancy. This assessment traditionally relied on manual reviews of medical records, actuarial data, and subjective interpretations by underwriters. However, with the advent of Electronic Health Records (EHRs), the landscape of life settlement underwriting is undergoing significant transformation. 

    Electronic Health Records are digital records of patients’ comprehensive health information, designed to be shared across different healthcare settings. They include virtually all components found in the paper records that comprise an insured’s medical history. In life settlement underwriting, EHRs potentially offer a more efficient and accurate method of accessing and analyzing an insured’s health data, which is pivotal in determining life expectancy and therefore, a fair price. 

    However, there are some challenges in utilizing EHR in an underwriting context. Before we address them, we should examine other electronically stored health information, which, when considered with EHR, comprise what is called Digital Health Data, and how they compare to EHR.  

    Types of Health Information in EHR 

    EHRs contain a vast array of health information that collectively provides a complete picture of an individual’s health: 

    • Patient Demographics: Basic data such as age, gender, ethnicity, and contact details. These are foundational for tailoring predictive models to specific population groups. 
    • Medical History: A detailed record of the patient’s past and present health conditions, surgeries, and treatments. This information is integral in assessing the insured’s overall health trajectory. 
    • Medication History: Includes all prescribed medications, dosages, and adherence information. This data helps underwriters understand how well chronic conditions are managed. 
    • Diagnostic Test Results: EHRs provide lab results, imaging studies, and other diagnostic tests, which are vital for evaluating the insured’s current health status and potential risks. 
    • Treatment Plans and Progress Notes: Physicians’ notes and treatment plans offer insights into ongoing health management and future health outlooks. 
    • Social and Behavioral Determinants of Health: These include lifestyle choices, social support, and socioeconomic status, all of which can significantly influence life expectancy. 

    While EHRs are increasingly recognized for their comprehensive nature, other types of health data, such as claims data, patient portal data, and prescription data, are also used in life settlement underwriting. However, these data sources differ significantly from EHRs in terms of depth, context, and usability. 

    Claims data consist of billing records generated when healthcare providers submit claims to insurers. These records typically include basic information about diagnoses, procedures performed, and services provided. 

    Comparison with EHR: 

    • Detail and Context: Claims data are transactional and often lack the detailed clinical context found in EHRs. They provide information on what services were billed but not on the underlying clinical decisions or patient outcomes. 
    • Comprehensiveness: EHRs offer a holistic view of the patient’s health, including unbilled interactions, clinical notes, and test results, making them far more comprehensive than claims data. 

    Patient portals give individuals access to a subset of their health information, often including lab results, medications, and appointment summaries. However, the data available through patient portals is typically limited to what the patient or their healthcare provider deems necessary to share. 

    Comparison with EHR: 

    • Scope: Patient portal data is a subset of EHR data, often lacking in-depth medical history, detailed physician notes, and full diagnostic test results. 
    • Utility: While useful for patient engagement, patient portal data does not provide the comprehensive detail needed for accurate life settlement underwriting. 

    Prescription data encompasses records of prescribed medications (filled), including dosage, frequency, and the dispensing pharmacy. This data is useful in understanding a patient’s treatment regimen. 

    Comparison with EHR: 

    • Context: Prescription data is focused solely on filled medications, without the accompanying clinical context that EHRs provide, such as why a medication was prescribed or how it fits into a broader treatment plan. 
    • Depth: EHR include prescription information (prescribed and filled) as part of a wider health record, allowing underwriters to see how prescriptions interact with other aspects of the patient’s health, offering a more nuanced understanding of their health status. 

    The chart below summarizes the realm of Digital Health Data and their application in life settlement underwriting: 

    Figure 1 Digital Health Data Sources and Life Settlement Underwriting 

    EHR Hit Rates and Quality of Data 

    Hit rates refer to the success rate of retrieving relevant and actionable health data from EHR systems. In life settlement underwriting, high hit rates are essential for making informed decisions. Current studies show that hit rates range from 30% to 45% in well-established healthcare networks. However, these rates can vary based on geographic location and the specific EHR systems in use. 

    High-quality EHR data is characterized by its accuracy, completeness, and timeliness. However, issues with data entry errors, or incomplete records, can impact reliability. Nevertheless, continuous advancements in EHR technology, normalization and standardization efforts are steadily improving data quality, making it more effective. 

    EHR Integration 

    Integrating EHR data into existing models or systems requires technical expertise and involves several key steps: 

    • Data Extraction: Extracting relevant data from EHR systems. 
    • Data Cleansing: Removing inaccuracies and standardizing data formats. 
    • Feature Engineering: Identifying and transforming data points into usable features in predictive models. 
    • Model Training: Training machine learning algorithms using historical data to predict outcomes based on current EHR data. 
    • Validation: Ensuring the model’s accuracy by validating it against real-world data. 

    EHR data continues to evolve and become more useable in their native state directly, being produced as organized data extracts of medical information and even summaries. Data users are creating interfaces, enabling underwriters to quickly access the relevant information they need. Moreover, integrating EHR data with existing underwriting systems streamlines the workflow, reducing the time and effort.  

    Challenges 

    Several challenges persist in the widespread adoption of EHR in life settlement underwriting: 

    • Data Standardization: Despite standardization of data formats across various EHR systems there still exists significant inconsistencies and variability of data leading to difficulties in interpretation and the creation of a cohesive medical picture. 
    • Hit Rates: There has been continuous growth in EHR hit rates, but increased availability is needed. Data providers continue their efforts to improve inoperability, standardization, and creating advance search algorithms to accelerate the hit rate growth.  
    • Regulatory and Compliance Issues: Navigating the complex regulatory landscape surrounding EHR data use and HIPAA remains a significant challenge. 
    • Integration: see below. 

    Integration 

    The implementation of EHR is fraught with technical and organizational challenges. Technical hurdles include integrating disparate EHR data sources and using NLP (natural language processing) with AI to synthesize large volumes of data. Education and training of industry participants who are accustomed to traditional underwriting methods is vital to successfully adopting EHR. It is also critical to establish a strategy on how to parse and analyze the voluminous data that is obtained. Clearly, this is not comparable to obtaining paper records and sending them to the underwriter. Significant IT resources, well-versed in underwriting, optical character recognition, AI and NLP, are crucial to having success. 

    Looking to the future, the role of EHR in life settlement underwriting is expected to grow. Advances in artificial intelligence and machine learning will likely enhance the ability to interpret and utilize EHR data more effectively. Additionally, emerging technologies like blockchain could address some of the privacy and security concerns associated with EHR data, potentially increasing the confidence of its users.  

    Studies from reinsurers suggest that EHRs will become increasingly integral to life underwriting processes. These organizations predict that as data quality improves and integration challenges are addressed, the use of EHRs will expand, leading to more accurate underwriting and better risk management. 

    In conclusion, the integration of EHRs into life settlement underwriting represents a significant advancement in the industry. EHRs provide a comprehensive and accurate view of an insured’s health, leading to more precise life expectancy assessments and better pricing of life settlement policies. However, challenges still exist and must be addressed to fully realize the potential of EHRs in this space. 

    Roger Tafoya is President & Chief Underwriter at Predictive Resources 


    Any views expressed in this article are those of the author(s) and may not necessarily represent those of Life Risk News or its publisher, the European Life Settlement Association

    2024 - August Commentary Life Settlements Longevity Risk Volume 3 Issue 8 - August 2024
    Share. Twitter LinkedIn Email

    Related Posts

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Just Group

    Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

    May 11, 2026By LMI Newsdesk

    UK Equity Release Market Origination Slows To Begin 2026

    May 6, 2026By LMI Newsdesk
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.